Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Stock-based Compensation and Other Benefit Plans - SAR Activity (Details)

v3.22.2.2
Note 15 - Stock-based Compensation and Other Benefit Plans - SAR Activity (Details) - Stock Appreciation Rights (SARs) [Member]
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Outstanding, number of underlying shares (in shares) | shares 362
Outstanding, weighted average exercise price per share (in dollars per share) | $ / shares $ 1.81
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares 0
Granted, weighted average exercise price per share (in dollars per share) | $ / shares $ 0
Exercised, number of underlying shares (in shares) | shares (153)
Exercised, weighted average exercise price per share (in dollars per share) | $ / shares $ 1.71
Unvested SARs forfeited, number of underlying shares (in shares) | shares 0
Unvested SARs forfeited, weighted average exercise price per share (in dollars per share) | $ / shares $ 0
Vested SARs expired, number of underlying shares (in shares) | shares 0
Vested SARs expired, weighted average exercise price per share (in dollars per share) | $ / shares $ 0
Outstanding, number of underlying shares (in shares) | shares 209
Outstanding, weighted average exercise price per share (in dollars per share) | $ / shares $ 1.88
Outstanding, weighted average remaining contractual term (Year) 1 year 1 month 9 days
Outstanding, aggregate intrinsic value | $ $ 517
Exercisable, number of underlying shares (in shares) | shares 209
Exercisable, weighted average exercise price per share (in dollars per share) | $ / shares $ 1.88
Exercisable, weighted average remaining contractual term (Year) 1 year 1 month 9 days
Exercisable, aggregate intrinsic value | $ $ 517